Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 2
1950 1
1951 4
1953 3
1954 5
1955 6
1956 10
1957 9
1958 8
1959 6
1960 13
1961 21
1962 27
1963 38
1964 101
1965 50
1966 57
1967 59
1968 76
1969 85
1970 72
1971 94
1972 69
1973 102
1974 106
1975 120
1976 106
1977 126
1978 125
1979 132
1980 116
1981 107
1982 156
1983 157
1984 177
1985 187
1986 190
1987 189
1988 168
1989 230
1990 195
1991 203
1992 206
1993 168
1994 216
1995 217
1996 233
1997 221
1998 219
1999 214
2000 262
2001 207
2002 236
2003 252
2004 258
2005 265
2006 309
2007 298
2008 305
2009 310
2010 324
2011 317
2012 379
2013 349
2014 393
2015 346
2016 383
2017 322
2018 300
2019 337
2020 355
2021 325
2022 304
2023 250
2024 261
2025 236
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,287 results

Results by year

Filters applied: . Clear all
Page 1
Melphalan.
Betcher DL, Burnham N. Betcher DL, et al. J Pediatr Oncol Nurs. 1990 Jan;7(1):35-6. doi: 10.1177/104345429000700110. J Pediatr Oncol Nurs. 1990. PMID: 2363868 No abstract available.
Melphalan Flufenamide (Melflufen): First Approval.
Dhillon S. Dhillon S. Drugs. 2021 Jun;81(8):963-969. doi: 10.1007/s40265-021-01522-0. Drugs. 2021. PMID: 33961277 Review.
It is an ethyl ester of a lipophilic dipeptide consisting of melphalan and para-fluoro-L-phenylalanine. Due to its lipophilicity, melphalan flufenamide is rapidly transported across the cell membrane and almost immediately hydrolyzed by aminopeptidases in the cytopl …
It is an ethyl ester of a lipophilic dipeptide consisting of melphalan and para-fluoro-L-phenylalanine. Due to its lipophilicity, …
Melphalan.
National Toxicology Program. National Toxicology Program. Rep Carcinog. 2011;12:258-9. Rep Carcinog. 2011. PMID: 21860475 Free article. No abstract available.
Melphalan.
[No authors listed] [No authors listed] Rep Carcinog. 2004;11:III164. Rep Carcinog. 2004. PMID: 21089900 No abstract available.
Oral melphalan kinetics.
Alberts DS, Chang SY, Chen HS, Evans TL, Moon TE. Alberts DS, et al. Clin Pharmacol Ther. 1979 Dec;26(6):737-45. doi: 10.1002/cpt1979266737. Clin Pharmacol Ther. 1979. PMID: 498715
The systemic availability of melphalan after oral administration is not well known. Most patients are put on a fixed oral dosage regimen. ...After oral dosing in 14 fasting patients, the time at which melphalan first appeared in the plasma varied between 15 min and …
The systemic availability of melphalan after oral administration is not well known. Most patients are put on a fixed oral dosage regi …
Melphalan: Recent insights on synthetic, analytical and medicinal aspects.
Pahwa R, Chhabra J, Kumar R, Narang R. Pahwa R, et al. Eur J Med Chem. 2022 Aug 5;238:114494. doi: 10.1016/j.ejmech.2022.114494. Epub 2022 May 27. Eur J Med Chem. 2022. PMID: 35665692 Review.
Several studies across the globe suggest that resistance to melphalan is the major concern that leads to relapsed myeloma. In the present paper, several pivotal approaches to compensate resistance associated with melphalan have been discussed. Numerous chemical and …
Several studies across the globe suggest that resistance to melphalan is the major concern that leads to relapsed myeloma. In the pre …
Melphalan hydrochloride for the treatment of multiple myeloma.
Esma F, Salvini M, Troia R, Boccadoro M, Larocca A, Pautasso C. Esma F, et al. Expert Opin Pharmacother. 2017 Aug;18(11):1127-1136. doi: 10.1080/14656566.2017.1349102. Epub 2017 Jul 10. Expert Opin Pharmacother. 2017. PMID: 28658983 Free article. Review.
Multiple myeloma (MM) is an incurable disease characterized by clonal plasma cell proliferation and overproduction of monoclonal paraprotein, hypercalcemia, renal failure, anemia, osteolytic bone lesions, and infections. Melphalan, a nitrogen mustard, is an alkylating agen …
Multiple myeloma (MM) is an incurable disease characterized by clonal plasma cell proliferation and overproduction of monoclonal paraprotein …
Melphalan.
National Toxicology Program. National Toxicology Program. Rep Carcinog. 2002;10:147. Rep Carcinog. 2002. Update in: Rep Carcinog. 2004;11:III164. PMID: 15326668 Updated. No abstract available.
o-Merphalan.
WHITE FR. WHITE FR. Cancer Chemother Rep. 1962 Nov;24:61-3. Cancer Chemother Rep. 1962. PMID: 14000312 No abstract available.
12,287 results
You have reached the last available page of results. Please see the User Guide for more information.